PD57-12 WHICH PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER SHOULD BE CONSIDERED FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL COLLABORATION

You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy IV (PD57)1 Sep 2021PD57-12 WHICH PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER SHOULD BE CONSIDERED FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL COLLABORATION Simone Scuderi, Elio Mazzone, Axel Heidenreich, Giorgio Gandaglia, David Pfister, Shahrok Shariat, Bernhard Grubmuller, Giuseppe Fallara,...